- Home
- PCVX vs WBA Comparison
PCVX vs WBA Comparison
Compare PCVX & WBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- WBA
- Stock Information
- Founded
- PCVX 2013
- WBA 1901
- Country
- PCVX United States
- WBA United States
- Employees
- PCVX N/A
- WBA N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- WBA Retail-Drug Stores and Proprietary Stores
- Sector
- PCVX Health Care
- WBA Consumer Staples
- Exchange
- PCVX Nasdaq
- WBA Nasdaq
- Market Cap
- PCVX 12.5B
- WBA 9.4B
- IPO Year
- PCVX 2020
- WBA N/A
- Fundamental
- Price
- PCVX $113.84
- WBA $8.95
- Analyst Decision
- PCVX Strong Buy
- WBA Hold
- Analyst Count
- PCVX 7
- WBA 14
- Target Price
- PCVX $147.50
- WBA $15.19
- AVG Volume (30 Days)
- PCVX 1.3M
- WBA 19.3M
- Earning Date
- PCVX 11-04-2024
- WBA 10-15-2024
- Dividend Yield
- PCVX N/A
- WBA 14.02%
- EPS Growth
- PCVX N/A
- WBA N/A
- EPS
- PCVX N/A
- WBA N/A
- Revenue
- PCVX N/A
- WBA $145,533,000,000.00
- Revenue This Year
- PCVX N/A
- WBA $5.66
- Revenue Next Year
- PCVX N/A
- WBA $1.02
- P/E Ratio
- PCVX N/A
- WBA N/A
- Revenue Growth
- PCVX N/A
- WBA 6.92
- 52 Week Low
- PCVX $44.20
- WBA $8.46
- 52 Week High
- PCVX $119.50
- WBA $27.05
- Technical
- Relative Strength Index (RSI)
- PCVX 79.65
- WBA 32.37
- Support Level
- PCVX $113.13
- WBA $8.56
- Resistance Level
- PCVX $119.50
- WBA $9.10
- Average True Range (ATR)
- PCVX 4.15
- WBA 0.39
- MACD
- PCVX 2.86
- WBA 0.01
- Stochastic Oscillator
- PCVX 86.13
- WBA 20.33
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About WBA Walgreens Boots Alliance Inc.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.